Sign in

CIK 0001712762

  • Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465211056
Phone
+1 210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-07-01 DIAMOND STUART Director Grant or award +33,784 99,088
2024-06-12 DIAMOND STUART Director Grant or award +8,296 65,304
2024-01-01 DIAMOND STUART Director Grant or award +12,668 $1.48 $19K 57,008
2023-10-01 DIAMOND STUART Director Grant or award +11,867 $1.58 $19K 44,340
2023-07-01 DIAMOND STUART Director Grant or award +10,245 $1.83 $19K 32,473
2023-04-15 DIAMOND STUART Director Grant or award +9,920 $1.89 $19K 22,228
2023-01-01 DIAMOND STUART Director Grant or award +8,227 $2.28 $19K 12,308
2022-08-31 DIAMOND STUART Director Purchase +4,081 4,081
2022-08-31 DIAMOND STUART Director Purchase · Warrants (right to buy) +4,081 4,081
2022-08-31 DIAMOND STUART Director Purchase · Non-tradeable Warrants (right to buy) +4,081 4,081

Page 1 of 1 · 10 trades